The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Utility of surgically documented minimal residual disease as a therapeutic target and early surrogate of frontline treatment outcomes in ovarian cancer.
 
Anne Knisely
No Relationships to Disclose
 
Roni Nitecki Wilke
No Relationships to Disclose
 
Bryan M. Fellman
No Relationships to Disclose
 
Jose Alejandro Rauh-Hain
Consulting or Advisory Role - Guidepoint Inc; Schlesinger Associates
 
Robert Tyler Hillman
Research Funding - Sumitomo Dainippon Pharma Oncology
 
Jolyn Sharpe Taylor
No Relationships to Disclose
 
Lois M. Ramondetta
No Relationships to Disclose
 
Michaela Onstad
No Relationships to Disclose
 
Lauren Patterson Cobb
No Relationships to Disclose
 
David M. Boruta
No Relationships to Disclose
 
Gwyn Richardson
No Relationships to Disclose
 
Pamela T. Soliman
Honoraria - Medscape
Consulting or Advisory Role - AADi; AADi; Amgen; Clovis Oncology; Eisai; GlaxoSmithKline; WebMD
Research Funding - Incyte (Inst); Novartis (Inst)
 
Aaron Shafer
No Relationships to Disclose
 
Shannon Neville Westin
Consulting or Advisory Role - AstraZeneca; Bayer; BioAscent; Caris Life Sciences; Clovis Oncology; Curio Science; Eisai; EQRX; Genentech; Gerson Lehrman Group; GlaxoSmithKline; Immunogen; Lilly; Medscape; Merck; Mereo BioPharma; Mersana; NGM Biopharmaceuticals; Nuvectis Pharma; OncLive; Roche; Seagen; Targeted Oncology; Vaniam Group; Vincerx Pharma; Zentalis
Research Funding - AstraZeneca (Inst); Avenge Bio (Inst); Bayer (Inst); Bio-Path Holdings, Inc (Inst); Clovis Oncology (Inst); GlaxoSmithKline (Inst); GOG Foundation (Inst); Mereo BioPharma (Inst); Novartis (Inst); OncXerna Therapeutics (Inst); Roche/Genentech (Inst); Zentalis (Inst)
 
Nicole D. Fleming
Consulting or Advisory Role - GlaxoSmithKline; Immunogen; Pfizer; Tesaro
 
Travis T. Sims
No Relationships to Disclose
 
Anil K Sood
Employment - Amgen (I)
Stock and Other Ownership Interests - Bio-Path Holdings, Inc
Honoraria - AstraZeneca; Merck
Consulting or Advisory Role - GlaxoSmithKline; ImmunoGen; Iylon; KIYATEC; Merck
Research Funding - MTrap
Patents, Royalties, Other Intellectual Property - EGFL6 antibody royalty payments; siRNA delivery patents on DOPC, rHDL
(OPTIONAL) Uncompensated Relationships - Elsevier
 
Pedro T. Ramirez
No Relationships to Disclose
 
Karen H. Lu
No Relationships to Disclose
 
Amir A. Jazaeri
Stock and Other Ownership Interests - Avenge Bio; Greenfire Bio
Honoraria - Gerson Lehrman Group; Guidepoint Global
Consulting or Advisory Role - Adicet Bio; Alkermes; Macrogenics; NuProbe; Theolytics
Research Funding - Aravive (Inst); AstraZeneca (Inst); Avenge Bio (Inst); Bristol-Myers Squibb (Inst); immatics (Inst); Iovance Biotherapeutics (Inst); Lilly (Inst); Macrogenics (Inst); Merck (Inst); Pfizer (Inst); Xencor (Inst)